In our case series, Patients 1 and 2 started growth hormone replacement in adulthood, when obesity was concurrently addressed with semaglutide
Lorenz M, Lawson F, Owens D, et al
While injectables remain a cornerstone of the market, Eli Lilly and its rivals are also turning their attention to pill versions of the drugs: In December, the Food and Drug Administration approved the first GLP-1 weight-loss pill: Novo Nordisks Wegovy
Orlistat [Internet]
Trials show IGF-1 rises while other pituitary hormones stay in their normal ranges
Hydroxypropyl methylcellulose (HPMC), polyvinylpyrrolidone (PVP), and microcrystalline cellulose (MCC), to name a few, are commonly used as matrix formers, binders, and fillers in tablet formulations